133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
T +64 4 496 2000
W www.medsafe.govt.nz
12 May 2021
Tracy Livingston
By email:
[FYI request #15191 email]
Ref:
H202104571
Dear Tracy Livingston
Response to your request for official information
Thank you for your follow request under the Official Information Act 1982 (the Act) to the Ministry
of Health (the Ministry) on 15 April 2021 for:
“There were 58 conditions on the conditional approval of the Pfizer vaccine for NZ. These
included requests for interim reports as follows:
5. Any homology between translated proteins (other than the intended spike protein) and
human proteins that may, due to molecular mimicry, potentially cause an autoimmune
process should be evaluated. Due date: July 2021. Interim report: March 2021.
DNA, lipid and elemental impurities. Due dates: July 2021; July 2021, Interim: March 2021;
July 2021.
28. The in-house controls applied to the raw materials and solvents used should also be
detailed, as should the control of any potentially genotoxic contaminants. Due date: July
2021, Interim: February 2021.
Since it is now mid-April I presume Medsafe has those reports. Since New Zealanders lives
and health is at stake, I would like copies of those three interim reports, and any others that
Medsafe requested, at your earliest convenience.
Information pertaining to your request is withheld under section 9(2)(b)(ii) of the Act, where its
release would likely unreasonably prejudice the commercial position of the person who supplied
the information.
For your reference, progress of the conditions on the approval of the Pfizer vaccine will soon be
made publicly available on the Medsafe website.
Under section 28(3) of the Act you have the right to ask the Ombudsman to review any decisions
made under this request. The Ombudsman may be contacted by email at:
[email address] or by calling 0800 802 602.
Yours sincerely
Chris James
Group Manager
Medsafe